Ch3-Lec 3- Good Manufacturing and Compounding Practices Flashcards

1
Q

Standards for good cGMPs

A

•Regulations are established by the FDA
–Purpose: to set minimum standards for product quality
–Kefauver-Harris inspired the first set of GMP regulations
–Establish requirements for all aspects of pharmaceutical manufacture
–No distinction in how regulations are applied to domestic and foreign suppliers and manufacturers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

cGMP for Finished Pharmaceuticals- 1

A

•Batch
•Batchwise control
•Certification
•Compliance
•Component
•Drug Product
•Inactive ingredient
•Lot
•Lot number
•Master record
Study Definitions on page 67 of textbook

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

cGMP for Finished Pharmaceuticals- 2

A

Quality assurance
•Quality audit
•Quality control
•Quality control unit
•Quarantine
•Representative sample
•Reprocessing
•Strength
•Verified
•Validation
Study Definitions on Page 67-68 of textbook

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

**Quality control unit: **

A

Any person or organizational element designated by the firm to be responsible for the duties relating to quality control

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

**Theoretical Yield: **

A

Quantity that would be produced at any appropriate phase of manufacture, in the absence of any loss of error

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Actual Yield:

A

Quantity that is actually produced at any appropriate phase of manufacture.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the name of the regulatory process through which industry measures quality performance, and compares to standards?

A

_ (A) Quality assurance
–(B) Quality audit
–(C) Quality control
–(D) Quality control unit

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Organization and Personnel:

A

–This division is responsible for
•Quality control and employees
–Responsibilities are,
•Assess product components and reject if necessary
•Assess product specifications, finished products, standards of packaging and labeling
•Adequate education and training is a must

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Buildings and Facilities:

A

–Must be designed to enable thorough cleaning, inspection, safe & effective use for performance operations and evaluations
•Weighing and measuring rooms
•Sterile areas
•Flammable storage areas
•Material storage areas
•All must be consistent with Occupational safety & Health Administration Regulations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Equipment

A

•Exact to the specifications
–The type of equipment
–Where the equipment is located
–Parts of equipment must not interfere with development of drug products
–Filter materials must not mix with injectable drug products. This must be prevented.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Control of components, containers, and closures

A

•Bulk chemical ingredients of drug products must meet all specifications at time of ordering
•When ingredients are received they must be officially logged in.
•Purchase order number
•Date of receipt
•Control number
•Quantity received
• Raw materials are quarantined quality verified. Materials that don’t meet specifications are rejected

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Production and process controls

A

–Written documentation is required to make sure that each drug product has the
•Correct identity
•Correct strength
•Correct quality
•Correct purity
–All automated equipment is evaluated
–Batches are evaluated from time to time to check on batch-batch consistency
•Production personnel
•Quality control laboratory

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Packaging and Labeling Control

A

•Written documentation is required for
•Receipt, storage, handling, sampling and testing of products
•All outdated labels must be destroyed
•When drug products need further investigation by quality control unit the problems must be identified and resolved
•When drug products are approved by quality control visual and/or electronic inspection is performed
•This prevents mislabeling of products
•Check for expiration date
•Tamper-evident packaging required

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Records and Reports

A

•Production information must be maintained on file for at least 1 year following expiration date of batch
•Control records must include
–Name and Strength of product dosage form
–Components and dosage units
–Control procedures
–Equipment used
–In-process controls
–Results of analysis
–Calibration of instruments

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Returned and Salvaged Drug Products
•What do you do when products come back from the marketplace?

A

•If the products happen to meet all product specifications they may be used again.
•If the products have not been stored under appropriate condition these should never see marketplace again
•Exact reason for product return must be documented and dated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Additional cGMP Regulatory Requirements

A

•Pharmaceutical excipients must be produced according to cGMP specifications.
NO FDA APPROVAL SYSTEM FOR PHARMACEUTICAL EXCIPIENTS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Clinical Trial Materials

A

•Pharmaceutical product are continuously being characterized and optimized for human treatment from phase 1 to phase 2.
•All regulatory requirements must be met by phase 3 and reported to the FDA
•For i.e., production of 100,000 capsules
•Placebos must be prepared by this stage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Current Good Compounding Practices
•Patient-specific medications, Why?

A

–Dosages are not commercially available
–Certain dosage forms are not available
–Patients are allergic to certain excipients
–Children have different needs
–Some medicines require frequent dispensing
–Some medicines not yet available by manufacturer
–Physicians have different needs
–Veterinary products not always available
–Home health care pharmacies: Sterile preparations
–Hospice care: new approaches to pain management
_____________________________________________________
See page 77 of textbook for more detailed descriptions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

FDA recognizes importance of compounding: Under section 127 of Public Law 105-115
•FDA modernization Act of 1997

A

–Ensured patients’ access to compounded products
–Prevented unnecessary FDA regulation of health professional (pharmacy) practice, but did not exempt the drug manufacturing company

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Packaging, Labeling, and Storage of Pharmaceuticals

A

•Containers:
–Must meet specifications for clinical trials
–Specifications vary according to container type, I.e.,
–Parenterals and non-parenterals
–Pressurized
–Glass, plastic and metal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Plastic vs. Glass containers

A

•Plastic containers have advantage over glass containers,
–Lightness in terms of weight
–Greater flexibility in terms of design and appearance
–Plastic squeeze bottle
•Autoclavable Plastic:
–Methyl groups to every other carbon atom of polyethylene will produce polypropylene (autoclavable)
–Polyvinyl chloride (PVC): strong and rigid material useful for packaging capsules and tablets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What are the problems with plastic containers over glass?

A

•Permeability of containers
•Leaching of constituents of container
•Absorption of drug to container
•Transmission of light through container
•Change in container material overtime

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Child-resistant and Adult-Senior use packaging:
•Why?

A

–To prevent accidental poisoning
•Child-resistant container is one that is difficult to open by children under 5 years of age
•Designs used to prevent children from opening containers are,
•Align arrows,
•press down and turn
•Squeeze and turn
•Latch top
Certain drugs are exempt due to practical considerations, sublingual tablets, cardiac drugs due to immediate access.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Compliance Packaging

A

•Labeling
•Prescription Label
•OTC Labeling
•Storage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Labeling

A

•Must meet Code of Federal Regulations
•Labeling includes immediate container, packaging, inserts, company literature, brochures, and any mailings
•Benefit to risks factors must be indicated in the packaging inserts….. Full Disclosure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Prescription Label
•Pharmacist must include the following when filling a prescription

A

•Name and address of pharmacy
•Serial number of prescription
•Date of prescription
•Name of the prescriber
•Name of patient
•Directions for use
_______________________________________________
See what additional information State laws may require, page 89

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

OTC Labeling in 1997

A

•FDA developed standard procedure for labeling OTC drug products due to inconsistent practices
•FDA called for simple headings and subheadings for easy understanding
•OTC package labeling must contain warning statements if misuse can lead to serious complications

28
Q

OTC labeling: What is required on the label?

A
  • Name and address of the manufacturer, packer, or distributer

•Product name
•Net quantity of contents
–This includes all ingredients
•Must indicate pharmacologic category
•Cautions and warnings to protect consumer
•Sodium content (for oral products) when necessary
•5 mg or more per single dose
•140 mg or more in maximum dose
•Storage conditions
–Must include storage in safe place out of the reach of children
–Lot number and expiration date

  • Any anticipating side effects
29
Q

OTC warnings

A

•Medication may lead to serious complications
•Ex: Laxatives may cause additional pain during an appendicitis. For this reason,
•“Warning: Do no use when abdominal pain, nausea, or vomiting is present. Frequent or prolonged use of this preparation may result in dependence on laxatives”

30
Q

OTC warnings 2

A

•Medications can mask as serious condition requiring medical attention
•Ex: how serious is a cough?
•“Warning: A persistent cough may be a sign of a serious condition. If cough persists for more than 1 week, tends to recur, or is accompanied by a fever, rash, or persistent headache, consult a doctor ”

31
Q

Dietary Supplement Labeling
Figure 3.8; See Ansel’s Textbook pg. 88

A

•Claims must be accurate and truthful
•No disease claims allowed
•For ex, those that infer “drug can be used to prevent, treat cure, mitigate, or diagnose a disease.”

32
Q

Storage

A

•To ensure stability of pharmaceutical preparation
•The following are conditions defined by USP
•Cold: 8 ºC (46 ºF)
•Cool: Between 8 ºC and 15 ºC
•Room Temp: 20 ºC to 25 ºC
•Warm: Between 30 and 40 ºC
•Excessive Heat: Above 40 ºC

33
Q

Transportation

A

•Must maintain appropriate conditions of temperature and humidity during shipment
•Special consideration may be needed
manufacturer
wholesale
Pharmacy
Patient

34
Q

•Regulations are established by the FDA
–Purpose: to set minimum standards for product quality
–Kefauver-Harris inspired the first set of GMP regulations
–Establish requirements for all aspects of pharmaceutical manufacture
–No distinction in how regulations are applied to domestic and foreign suppliers and manufacturers

A

Standards for good cGMPs

35
Q

•Batch
•Batchwise control
•Certification
•Compliance
•Component
•Drug Product
•Inactive ingredient
•Lot
•Lot number
•Master record
Study Definitions on page 67 of textbook

A

cGMP for Finished Pharmaceuticals- 1

36
Q

Quality assurance
•Quality audit
•Quality control
•Quality control unit
•Quarantine
•Representative sample
•Reprocessing
•Strength
•Verified
•Validation
Study Definitions on Page 67-68 of textbook

A

cGMP for Finished Pharmaceuticals- 2

37
Q

Any person or organizational element designated by the firm to be responsible for the duties relating to quality control

A

**Quality control unit: **

38
Q

Quantity that would be produced at any appropriate phase of manufacture, in the absence of any loss of error

A

**Theoretical Yield: **

39
Q

Quantity that is actually produced at any appropriate phase of manufacture.

A

Actual Yield:

40
Q

_ (A) Quality assurance
–(B) Quality audit
–(C) Quality control
–(D) Quality control unit

A

What is the name of the regulatory process through which industry measures quality performance, and compares to standards?

41
Q

–This division is responsible for
•Quality control and employees
–Responsibilities are,
•Assess product components and reject if necessary
•Assess product specifications, finished products, standards of packaging and labeling
•Adequate education and training is a must

A

Organization and Personnel:

42
Q

–Must be designed to enable thorough cleaning, inspection, safe & effective use for performance operations and evaluations
•Weighing and measuring rooms
•Sterile areas
•Flammable storage areas
•Material storage areas
•All must be consistent with Occupational safety & Health Administration Regulations

A

Buildings and Facilities:

43
Q

•Exact to the specifications
–The type of equipment
–Where the equipment is located
–Parts of equipment must not interfere with development of drug products
–Filter materials must not mix with injectable drug products. This must be prevented.

A

Equipment

44
Q

•Bulk chemical ingredients of drug products must meet all specifications at time of ordering
•When ingredients are received they must be officially logged in.
•Purchase order number
•Date of receipt
•Control number
•Quantity received
• Raw materials are quarantined quality verified. Materials that don’t meet specifications are rejected

A

Control of components, containers, and closures

45
Q

–Written documentation is required to make sure that each drug product has the
•Correct identity
•Correct strength
•Correct quality
•Correct purity
–All automated equipment is evaluated
–Batches are evaluated from time to time to check on batch-batch consistency
•Production personnel
•Quality control laboratory

A

Production and process controls

46
Q

•Written documentation is required for
•Receipt, storage, handling, sampling and testing of products
•All outdated labels must be destroyed
•When drug products need further investigation by quality control unit the problems must be identified and resolved
•When drug products are approved by quality control visual and/or electronic inspection is performed
•This prevents mislabeling of products
•Check for expiration date
•Tamper-evident packaging required

A

Packaging and Labeling Control

47
Q

•Production information must be maintained on file for at least 1 year following expiration date of batch
•Control records must include
–Name and Strength of product dosage form
–Components and dosage units
–Control procedures
–Equipment used
–In-process controls
–Results of analysis
–Calibration of instruments

A

Records and Reports

48
Q

•If the products happen to meet all product specifications they may be used again.
•If the products have not been stored under appropriate condition these should never see marketplace again
•Exact reason for product return must be documented and dated

A

Returned and Salvaged Drug Products
•What do you do when products come back from the marketplace?

49
Q

•Pharmaceutical excipients must be produced according to cGMP specifications.
NO FDA APPROVAL SYSTEM FOR PHARMACEUTICAL EXCIPIENTS

A

Additional cGMP Regulatory Requirements

50
Q

•Pharmaceutical product are continuously being characterized and optimized for human treatment from phase 1 to phase 2.
•All regulatory requirements must be met by phase 3 and reported to the FDA
•For i.e., production of 100,000 capsules
•Placebos must be prepared by this stage

A

Clinical Trial Materials

51
Q

–Dosages are not commercially available
–Certain dosage forms are not available
–Patients are allergic to certain excipients
–Children have different needs
–Some medicines require frequent dispensing
–Some medicines not yet available by manufacturer
–Physicians have different needs
–Veterinary products not always available
–Home health care pharmacies: Sterile preparations
–Hospice care: new approaches to pain management
_____________________________________________________
See page 77 of textbook for more detailed descriptions

A

Current Good Compounding Practices
•Patient-specific medications, Why?

52
Q

–Ensured patients’ access to compounded products
–Prevented unnecessary FDA regulation of health professional (pharmacy) practice, but did not exempt the drug manufacturing company

A

FDA recognizes importance of compounding: Under section 127 of Public Law 105-115
•FDA modernization Act of 1997

53
Q

•Containers:
–Must meet specifications for clinical trials
–Specifications vary according to container type, I.e.,
–Parenterals and non-parenterals
–Pressurized
–Glass, plastic and metal

A

Packaging, Labeling, and Storage of Pharmaceuticals

54
Q

•Plastic containers have advantage over glass containers,
–Lightness in terms of weight
–Greater flexibility in terms of design and appearance
–Plastic squeeze bottle
•Autoclavable Plastic:
–Methyl groups to every other carbon atom of polyethylene will produce polypropylene (autoclavable)
–Polyvinyl chloride (PVC): strong and rigid material useful for packaging capsules and tablets

A

Plastic vs. Glass containers

55
Q

•Permeability of containers
•Leaching of constituents of container
•Absorption of drug to container
•Transmission of light through container
•Change in container material overtime

A

What are the problems with plastic containers over glass?

56
Q

–To prevent accidental poisoning
•Child-resistant container is one that is difficult to open by children under 5 years of age
•Designs used to prevent children from opening containers are,
•Align arrows,
•press down and turn
•Squeeze and turn
•Latch top
Certain drugs are exempt due to practical considerations, sublingual tablets, cardiac drugs due to immediate access.

A

Child-resistant and Adult-Senior use packaging:
•Why?

57
Q

•Labeling
•Prescription Label
•OTC Labeling
•Storage

A

Compliance Packaging

58
Q

•Must meet Code of Federal Regulations
•Labeling includes immediate container, packaging, inserts, company literature, brochures, and any mailings
•Benefit to risks factors must be indicated in the packaging inserts….. Full Disclosure

A

Labeling

59
Q

•Name and address of pharmacy
•Serial number of prescription
•Date of prescription
•Name of the prescriber
•Name of patient
•Directions for use
_______________________________________________
See what additional information State laws may require, page 89

A

Prescription Label
•Pharmacist must include the following when filling a prescription

60
Q

•FDA developed standard procedure for labeling OTC drug products due to inconsistent practices
•FDA called for simple headings and subheadings for easy understanding
•OTC package labeling must contain warning statements if misuse can lead to serious complications

A

OTC Labeling in 1997

61
Q

•Product name
•Net quantity of contents
–This includes all ingredients
•Must indicate pharmacologic category
•Cautions and warnings to protect consumer
•Sodium content (for oral products) when necessary
•5 mg or more per single dose
•140 mg or more in maximum dose
•Storage conditions
–Must include storage in safe place out of the reach of children
–Lot number and expiration date

A

OTC labeling: What is required on the label?

62
Q

•Medication may lead to serious complications
•Ex: Laxatives may cause additional pain during an appendicitis. For this reason,
•“Warning: Do no use when abdominal pain, nausea, or vomiting is present. Frequent or prolonged use of this preparation may result in dependence on laxatives”

A

OTC warnings

63
Q

•Medications can mask as serious condition requiring medical attention
•Ex: how serious is a cough?
•“Warning: A persistent cough may be a sign of a serious condition. If cough persists for more than 1 week, tends to recur, or is accompanied by a fever, rash, or persistent headache, consult a doctor ”

A

OTC warnings 2

64
Q

•Claims must be accurate and truthful
•No disease claims allowed
•For ex, those that infer “drug can be used to prevent, treat cure, mitigate, or diagnose a disease.”

A

Dietary Supplement Labeling
Figure 3.8; See Ansel’s Textbook pg. 88

65
Q

•To ensure stability of pharmaceutical preparation
•The following are conditions defined by USP
•Cold: 8 ºC (46 ºF)
•Cool: Between 8 ºC and 15 ºC
•Room Temp: 20 ºC to 25 ºC
•Warm: Between 30 and 40 ºC
•Excessive Heat: Above 40 ºC

A

Storage

66
Q

•Must maintain appropriate conditions of temperature and humidity during shipment
•Special consideration may be needed
manufacturer
wholesale
Pharmacy
Patient

A

Transportation